Biomaterial property-controlled stem cell fates for cardiac regeneration
- PMID: 29744392
- PMCID: PMC5883968
- DOI: 10.1016/j.bioactmat.2016.03.002
Biomaterial property-controlled stem cell fates for cardiac regeneration
Abstract
Myocardial infarction (MI) affects more than 8 million people in the United States alone. Due to the insufficient regeneration capacity of the native myocardium, one widely studied approach is cardiac tissue engineering, in which cells are delivered with or without biomaterials and/or regulatory factors to fully regenerate the cardiac functions. Specifically, in vitro cardiac tissue engineering focuses on using biomaterials as a reservoir for cells to attach, as well as a carrier of various regulatory factors such as growth factors and peptides, providing high cell retention and a proper microenvironment for cells to migrate, grow and differentiate within the scaffolds before implantation. Many studies have shown that the full establishment of a functional cardiac tissue in vitro requires synergistic actions between the seeded cells, the tissue culture condition, and the biochemical and biophysical environment provided by the biomaterials-based scaffolds. Proper electrical stimulation and mechanical stretch during the in vitro culture can induce the ordered orientation and differentiation of the seeded cells. On the other hand, the various scaffolds biochemical and biophysical properties such as polymer composition, ligand concentration, biodegradability, scaffold topography and mechanical properties can also have a significant effect on the cellular processes.
Keywords: Biomaterials; Cardiac differentiation; Cardiac tissue engineering; Myocardial infarction; Stem cell fate.
Figures
References
-
- Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K. Heart disease and stroke statistics–2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2007;115:e69–e171. - PubMed
-
- Taylor D.A. Cell-based myocardial repair: how should we proceed? International J. Cardiol. 2004;95(Suppl. 1):S8–S12. - PubMed
-
- Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature. 2008;451:937–942. - PubMed
-
- Li S.C., Wang L., Jiang H., Acevedo J., Chang A.C., Loudon W.G. Stem cell engineering for treatment of heart diseases: potentials and challenges. Cell Biol. Int. 2009;33:255–267. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
